Capwealth Advisors, LLC / GILD
Capwealth Advisors, LLC’s Gilead Sciences Inc Position
Does Capwealth Advisors, LLC own Gilead Sciences Inc (GILD)? Yes — 235.2K shares worth $33M (+2.43% of its 13F portfolio) as of Q1 2026, down from 244.6K shares the prior filed quarter.
Position Value
$33M
Q1 2026
Shares
235.2K
% of Portfolio
+2.43%
Quarters Held
28
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 235.2K | $33M | +2.43% |
| Q4 2025 | 244.6K | $30M | +2.05% |
| Q3 2025 | 487.2K | $54M | +2.10% |
| Q2 2025 | 252.9K | $28M | +2.76% |
| Q1 2025 | 254.2K | $28M | +3.08% |
| Q4 2024 | 253.7K | $23M | +2.57% |
| Q3 2024 | 258.0K | $22M | +2.35% |
| Q2 2024 | 257.6K | $18M | +2.23% |
| Q1 2024 | 268.0K | $20M | +2.20% |
| Q4 2023 | 263.1K | $21M | +2.60% |
| Q3 2023 | 270.5K | $20M | +2.60% |
| Q2 2023 | 275.8K | $21M | +2.59% |
| Q1 2023 | 279.7K | $23M | +2.89% |
| Q4 2022 | 283.9K | $24M | +2.86% |
| Q3 2022 | 284.8K | $18M | +2.32% |
| Q2 2022 | 281.0K | $17M | +2.09% |
| Q1 2022 | 271.7K | $16M | +1.65% |
| Q4 2021 | 275.6K | $20M | +2.04% |
| Q3 2021 | 272.8K | $19M | +2.09% |
| Q2 2021 | 272.1K | $19M | +2.03% |
| Q1 2021 | 233.2K | $15M | +1.71% |
| Q4 2020 | 212.0K | $12M | +1.47% |
| Q3 2020 | 151.1K | $10M | +1.28% |
| Q2 2020 | 148.8K | $11M | +1.62% |
| Q1 2020 | 137.2K | $10M | +1.81% |
| Q2 2019 | 11.4K | $767,000 | +0.11% |
| Q1 2019 | 82.2K | $5M | +0.82% |
| Q4 2018 | 91.2K | $6M | +1.00% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Capwealth Advisors, LLC’s full portfolio or all institutional holders of GILD.